Asia-Pacific Americas Africa Europe Middle East

BENEFICIARY DISHMAN CARBOGEN AMCIS LTD

Company Profile:

Company Information: Dishman Carbogen Amcis Ltd (India)

Company Type:

Dishman Carbogen Amcis Ltd is a manufacturer. It operates as a Contract Development and Manufacturing Organization (CDMO).

Company Introduction:

Dishman Carbogen Amcis Ltd, commonly known as DCAL, is a global pharmaceutical and life sciences company headquartered in Ahmedabad, Gujarat, India.

DCAL specializes in offering a wide range of Contract Development and Manufacturing Organization (CDMO) services. These services encompass research and development, process optimization, and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and specialty chemicals.

The company partners with pharmaceutical and biopharmaceutical companies globally, supporting them through various stages of drug development and commercial production. DCAL operates several manufacturing facilities that comply with current Good Manufacturing Practices (cGMP) and other stringent international regulatory requirements. The company is known for its expertise in complex chemical processes and its integrated solutions from early-stage development to commercial-scale manufacturing.

Enterprise Products

Based on publicly available information, Beneficiary Dishman Carbogen Amcis Ltd. (DCAL) produces and/or sells:

* Active Pharmaceutical Ingredients (APIs)

* Custom Synthesis products

* Contract Research and Manufacturing Services (CRAMS)

* Intermediates

* Quaternary ammonium compounds

* Phase transfer catalysts

Business Registration Information:

Manager:

Dr. Pascal Villemagne (Chief Executive Officer), Mr. Arpit Dishman (Managing Director)

Phone:

+91 79 26640822

E-mail:

info@dishmancarbogenamcis.com

Official Website:
Address:

Dishman Corporate House Swastik Cross Roads Navrangpura Ahmedabad - 380 009 Gujarat, India

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.